Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.14102 ↗Kurz gefasst
Editorial in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Beatrice Z Sim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Anti-Infective Agents, Bacteremia, Leukemia, Myeloid, Acute, Gram-Negative Bacterial Infections. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
MAS has been awarded grants from Gilead, Merck, and F2G, as well as honoraria from F2G, Pfizer, Merck, Takeda, and Gilead, and is on the data review/advisory boards of Pfizer, F2G, Cidara, Takeda, and Roche with all payments to an institution. APD has been awarded a grant and honoraria from Gilead, with all payments to an institution. BZS has no disclosures. Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
- Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Austin Health, Melbourne, Victoria, Australia.
ORCID-Profile: Beatrice Z Sim, Monica A Slavin, Abby P Douglas
Zitieren
APA
Sim, B. Z., Slavin, M. A., & Douglas, A. P. (2023). Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14102
Vancouver
Sim BZ, Slavin MA, Douglas AP. Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients. Transplant Infectious Disease. 2023. doi:10.1111/tid.14102
BibTeX
@article{Sim2023,
author = {Sim, Beatrice Z and Slavin, Monica A and Douglas, Abby P},
title = {Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.14102}
}
EUVIMED